Status:
COMPLETED
Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will implement a non-randomized observational clinical trial that will include a pop-up clinic for women who inject drugs (WWID) near venues for exchange sex and drug use in north Se...
Detailed Description
The investigators will implement a pilot clinic one evening per week, with the primary goal of measuring a community-based extension of SHE Clinic's impact on uptake and sustained use of HIV pre-expos...
Eligibility Criteria
Inclusion
- ≥18 years of age
- Female identifying
- Ever injected drugs
- Not known to have HIV
- Willing and able to provide informed consent to participate in the study
Exclusion
- \<18 years of age
- Never injected drugs
- Living with HIV
- Medical or psychological co-morbidities that prevent participation per study team assessment.
- Non-English speaking
Key Trial Info
Start Date :
March 18 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06187064
Start Date
March 18 2024
End Date
March 12 2025
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harborview Medical Center
Seattle, Washington, United States, 98104